Cancer

484 articles in this topic

Morning Immunotherapy Doubles Survival Time in Lung Cancer Trial
Cancer Research

Morning Immunotherapy Doubles Survival Time in Lung Cancer Trial

A phase 3 trial finds scheduling immunochemotherapy before 3 PM nearly doubles progression-free and overall survival in NSCLC patients.

Research Paper
Jun 1, 2026 0
Ginseng Compound Rh4 Fights Colorectal Cancer by Reshaping Gut Bacteria and Bile Acids
Cancer Research

Ginseng Compound Rh4 Fights Colorectal Cancer by Reshaping Gut Bacteria and Bile Acids

Ginsenoside Rh4 suppresses colorectal cancer by boosting Akkermansia muciniphila and elevating protective bile acid UDCA via FXR signaling.

Research Paper
Jun 1, 2026 0
Linvoseltamab Wins EU Approval for Hard-to-Treat Multiple Myeloma
Cancer Research

Linvoseltamab Wins EU Approval for Hard-to-Treat Multiple Myeloma

Regeneron's bispecific antibody linvoseltamab earns EU approval for relapsed/refractory multiple myeloma after at least three prior therapies.

Research Paper
May 31, 2026 0
New Kinase Target STK40 Cracks Open Liver Cancer Immune Resistance
Cancer Research

New Kinase Target STK40 Cracks Open Liver Cancer Immune Resistance

A CRISPR screen reveals STK40 suppresses anti-tumor immunity in liver cancer — blocking it supercharges immunotherapy response.

Research Paper
May 30, 2026 0
High Antigen Expression Can Backfire and Fuel ADC Resistance in Cancer
Cancer Research

High Antigen Expression Can Backfire and Fuel ADC Resistance in Cancer

A counterintuitive mechanism shows that more NECTIN4 antigen on tumor cells can actually blunt antibody-drug conjugate therapy.

Research Paper
May 30, 2026 0
Fat Cells Inside Pancreatic Tumors Sabotage Immune Defenses Via a Lipid Signal
Cancer Research

Fat Cells Inside Pancreatic Tumors Sabotage Immune Defenses Via a Lipid Signal

Tumor-infiltrating adipocytes release a lipid metabolite that triggers neutrophil cell death, suppressing CD8+ T cells in pancreatic cancer.

Research Paper
May 30, 2026 0
Genetic Testing Reveals Hidden Cancer Risks in Children Referred for Screening
Cancer Research

Genetic Testing Reveals Hidden Cancer Risks in Children Referred for Screening

A Nature Medicine study finds pathogenic germline variants in pediatric patients signal elevated cancer risk, reshaping early genetic screening protocols.

Research Paper
May 30, 2026 0
FGFR Inhibitor Achieves 42% Response Rate in Rare SDH-Deficient Stomach Tumors
Cancer Research

FGFR Inhibitor Achieves 42% Response Rate in Rare SDH-Deficient Stomach Tumors

A phase 2 trial shows rogaratinib produces durable responses in a hard-to-treat GIST subtype driven by epigenetic oncogene activation.

Research Paper
May 29, 2026 0
ctDNA Testing at Treatment Start Predicts Metastatic Prostate Cancer Outcomes
Cancer Research

ctDNA Testing at Treatment Start Predicts Metastatic Prostate Cancer Outcomes

Circulating tumor DNA testing alongside primary treatment may sharpen prognosis for men with metastatic prostate cancer.

Research Paper
May 28, 2026 0
How Colorectal Cancer Cells Survive Iron Overload by Hijacking Metabolism
Cancer Research

How Colorectal Cancer Cells Survive Iron Overload by Hijacking Metabolism

CRC cells exploit a heme-SDH-CoQ axis to neutralize iron-induced oxidative stress, revealing new therapeutic targets.

Research Paper
May 28, 2026 0
Vitamin D Receptor Agonist Reshapes Pancreatic Cancer's Defensive Shield
Cancer Research

Vitamin D Receptor Agonist Reshapes Pancreatic Cancer's Defensive Shield

A phase trial finds paricalcitol safely remodels the tumor microenvironment in metastatic pancreatic cancer, boosting immune cell infiltration.

Research Paper
May 26, 2026 0
Copper Depletion Plus Chemo Slows Brain Leukemia in Preclinical Models
Cancer Research

Copper Depletion Plus Chemo Slows Brain Leukemia in Preclinical Models

Removing dietary copper starves leukemia cells of nucleotide building blocks, boosting methotrexate efficacy against hard-to-treat CNS disease.

Research Paper
May 26, 2026 0
PreviousPage 7 of 41Next